Global Measles Vaccine Market Growth 2025-2031
The global Measles Vaccine market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Measles Vaccine Industry Forecast” looks at past sales and reviews total world Measles Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Measles Vaccine sales for 2025 through 2031. With Measles Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Measles Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Measles Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Measles Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Measles Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Measles Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Measles Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Measles Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Measles Vaccine market?
What factors are driving Measles Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Measles Vaccine market opportunities vary by end market size?
How does Measles Vaccine break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Measles Vaccine Industry Forecast” looks at past sales and reviews total world Measles Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Measles Vaccine sales for 2025 through 2031. With Measles Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Measles Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Measles Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Measles Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Measles Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Measles Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Measles Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Measles Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Mumps Measles Rubella Vaccine, Live (MMR-II)
- Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
- Children
- Adults
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GSK
- Sanofi-Pasteur
- Merck
- Novartis
- Pfizer
- Serum Institute of India
- China National Biotech Group
- Bavarian Nordic
- Emergent Biosolutions
- Medimmune
- Johnson & Johnson
- CSL Limited
What is the 10-year outlook for the global Measles Vaccine market?
What factors are driving Measles Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Measles Vaccine market opportunities vary by end market size?
How does Measles Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Lying Silkworm Pen Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Lying Silkworm Pen by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Lying Silkworm Pen by Country/Region, 2020, 2024 & 2031
2.2 Lying Silkworm Pen Segment by Type
2.2.1 Single Head Lying Silkworm Pen
2.2.2 Double Head Lying Silkworm Pen
2.3 Lying Silkworm Pen Sales by Type
2.3.1 Global Lying Silkworm Pen Sales Market Share by Type (2020-2025)
2.3.2 Global Lying Silkworm Pen Revenue and Market Share by Type (2020-2025)
2.3.3 Global Lying Silkworm Pen Sale Price by Type (2020-2025)
2.4 Lying Silkworm Pen Segment by Sale Channel
2.4.1 Specialist Retailers
2.4.2 Factory Outlets
2.4.3 Internet Sales
2.4.4 Other
2.5 Lying Silkworm Pen Sales by Sale Channel
2.5.1 Global Lying Silkworm Pen Sale Market Share by Sale Channel (2020-2025)
2.5.2 Global Lying Silkworm Pen Revenue and Market Share by Sale Channel (2020-2025)
2.5.3 Global Lying Silkworm Pen Sale Price by Sale Channel (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Lying Silkworm Pen Breakdown Data by Company
3.1.1 Global Lying Silkworm Pen Annual Sales by Company (2020-2025)
3.1.2 Global Lying Silkworm Pen Sales Market Share by Company (2020-2025)
3.2 Global Lying Silkworm Pen Annual Revenue by Company (2020-2025)
3.2.1 Global Lying Silkworm Pen Revenue by Company (2020-2025)
3.2.2 Global Lying Silkworm Pen Revenue Market Share by Company (2020-2025)
3.3 Global Lying Silkworm Pen Sale Price by Company
3.4 Key Manufacturers Lying Silkworm Pen Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Lying Silkworm Pen Product Location Distribution
3.4.2 Players Lying Silkworm Pen Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LYING SILKWORM PEN BY GEOGRAPHIC REGION
4.1 World Historic Lying Silkworm Pen Market Size by Geographic Region (2020-2025)
4.1.1 Global Lying Silkworm Pen Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Lying Silkworm Pen Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Lying Silkworm Pen Market Size by Country/Region (2020-2025)
4.2.1 Global Lying Silkworm Pen Annual Sales by Country/Region (2020-2025)
4.2.2 Global Lying Silkworm Pen Annual Revenue by Country/Region (2020-2025)
4.3 Americas Lying Silkworm Pen Sales Growth
4.4 APAC Lying Silkworm Pen Sales Growth
4.5 Europe Lying Silkworm Pen Sales Growth
4.6 Middle East & Africa Lying Silkworm Pen Sales Growth
5 AMERICAS
5.1 Americas Lying Silkworm Pen Sales by Country
5.1.1 Americas Lying Silkworm Pen Sales by Country (2020-2025)
5.1.2 Americas Lying Silkworm Pen Revenue by Country (2020-2025)
5.2 Americas Lying Silkworm Pen Sales by Type (2020-2025)
5.3 Americas Lying Silkworm Pen Sales by Sale Channel (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lying Silkworm Pen Sales by Region
6.1.1 APAC Lying Silkworm Pen Sales by Region (2020-2025)
6.1.2 APAC Lying Silkworm Pen Revenue by Region (2020-2025)
6.2 APAC Lying Silkworm Pen Sales by Type (2020-2025)
6.3 APAC Lying Silkworm Pen Sales by Sale Channel (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Lying Silkworm Pen by Country
7.1.1 Europe Lying Silkworm Pen Sales by Country (2020-2025)
7.1.2 Europe Lying Silkworm Pen Revenue by Country (2020-2025)
7.2 Europe Lying Silkworm Pen Sales by Type (2020-2025)
7.3 Europe Lying Silkworm Pen Sales by Sale Channel (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Lying Silkworm Pen by Country
8.1.1 Middle East & Africa Lying Silkworm Pen Sales by Country (2020-2025)
8.1.2 Middle East & Africa Lying Silkworm Pen Revenue by Country (2020-2025)
8.2 Middle East & Africa Lying Silkworm Pen Sales by Type (2020-2025)
8.3 Middle East & Africa Lying Silkworm Pen Sales by Sale Channel (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Lying Silkworm Pen
10.3 Manufacturing Process Analysis of Lying Silkworm Pen
10.4 Industry Chain Structure of Lying Silkworm Pen
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Lying Silkworm Pen Distributors
11.3 Lying Silkworm Pen Customer
12 WORLD FORECAST REVIEW FOR LYING SILKWORM PEN BY GEOGRAPHIC REGION
12.1 Global Lying Silkworm Pen Market Size Forecast by Region
12.1.1 Global Lying Silkworm Pen Forecast by Region (2026-2031)
12.1.2 Global Lying Silkworm Pen Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Lying Silkworm Pen Forecast by Type (2026-2031)
12.7 Global Lying Silkworm Pen Forecast by Sale Channel (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Holika
13.1.1 Holika Company Information
13.1.2 Holika Lying Silkworm Pen Product Portfolios and Specifications
13.1.3 Holika Lying Silkworm Pen Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Holika Main Business Overview
13.1.5 Holika Latest Developments
13.2 Lovedrops
13.2.1 Lovedrops Company Information
13.2.2 Lovedrops Lying Silkworm Pen Product Portfolios and Specifications
13.2.3 Lovedrops Lying Silkworm Pen Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Lovedrops Main Business Overview
13.2.5 Lovedrops Latest Developments
13.3 Kate
13.3.1 Kate Company Information
13.3.2 Kate Lying Silkworm Pen Product Portfolios and Specifications
13.3.3 Kate Lying Silkworm Pen Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Kate Main Business Overview
13.3.5 Kate Latest Developments
13.4 Dolly Wink
13.4.1 Dolly Wink Company Information
13.4.2 Dolly Wink Lying Silkworm Pen Product Portfolios and Specifications
13.4.3 Dolly Wink Lying Silkworm Pen Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Dolly Wink Main Business Overview
13.4.5 Dolly Wink Latest Developments
13.5 Solone
13.5.1 Solone Company Information
13.5.2 Solone Lying Silkworm Pen Product Portfolios and Specifications
13.5.3 Solone Lying Silkworm Pen Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Solone Main Business Overview
13.5.5 Solone Latest Developments
13.6 Etude House
13.6.1 Etude House Company Information
13.6.2 Etude House Lying Silkworm Pen Product Portfolios and Specifications
13.6.3 Etude House Lying Silkworm Pen Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Etude House Main Business Overview
13.6.5 Etude House Latest Developments
13.7 Innisfree
13.7.1 Innisfree Company Information
13.7.2 Innisfree Lying Silkworm Pen Product Portfolios and Specifications
13.7.3 Innisfree Lying Silkworm Pen Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Innisfree Main Business Overview
13.7.5 Innisfree Latest Developments
13.8 NYX
13.8.1 NYX Company Information
13.8.2 NYX Lying Silkworm Pen Product Portfolios and Specifications
13.8.3 NYX Lying Silkworm Pen Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 NYX Main Business Overview
13.8.5 NYX Latest Developments
13.9 Banila co
13.9.1 Banila co Company Information
13.9.2 Banila co Lying Silkworm Pen Product Portfolios and Specifications
13.9.3 Banila co Lying Silkworm Pen Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Banila co Main Business Overview
13.9.5 Banila co Latest Developments
13.10 Integrate
13.10.1 Integrate Company Information
13.10.2 Integrate Lying Silkworm Pen Product Portfolios and Specifications
13.10.3 Integrate Lying Silkworm Pen Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Integrate Main Business Overview
13.10.5 Integrate Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Lying Silkworm Pen Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Lying Silkworm Pen by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Lying Silkworm Pen by Country/Region, 2020, 2024 & 2031
2.2 Lying Silkworm Pen Segment by Type
2.2.1 Single Head Lying Silkworm Pen
2.2.2 Double Head Lying Silkworm Pen
2.3 Lying Silkworm Pen Sales by Type
2.3.1 Global Lying Silkworm Pen Sales Market Share by Type (2020-2025)
2.3.2 Global Lying Silkworm Pen Revenue and Market Share by Type (2020-2025)
2.3.3 Global Lying Silkworm Pen Sale Price by Type (2020-2025)
2.4 Lying Silkworm Pen Segment by Sale Channel
2.4.1 Specialist Retailers
2.4.2 Factory Outlets
2.4.3 Internet Sales
2.4.4 Other
2.5 Lying Silkworm Pen Sales by Sale Channel
2.5.1 Global Lying Silkworm Pen Sale Market Share by Sale Channel (2020-2025)
2.5.2 Global Lying Silkworm Pen Revenue and Market Share by Sale Channel (2020-2025)
2.5.3 Global Lying Silkworm Pen Sale Price by Sale Channel (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Lying Silkworm Pen Breakdown Data by Company
3.1.1 Global Lying Silkworm Pen Annual Sales by Company (2020-2025)
3.1.2 Global Lying Silkworm Pen Sales Market Share by Company (2020-2025)
3.2 Global Lying Silkworm Pen Annual Revenue by Company (2020-2025)
3.2.1 Global Lying Silkworm Pen Revenue by Company (2020-2025)
3.2.2 Global Lying Silkworm Pen Revenue Market Share by Company (2020-2025)
3.3 Global Lying Silkworm Pen Sale Price by Company
3.4 Key Manufacturers Lying Silkworm Pen Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Lying Silkworm Pen Product Location Distribution
3.4.2 Players Lying Silkworm Pen Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LYING SILKWORM PEN BY GEOGRAPHIC REGION
4.1 World Historic Lying Silkworm Pen Market Size by Geographic Region (2020-2025)
4.1.1 Global Lying Silkworm Pen Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Lying Silkworm Pen Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Lying Silkworm Pen Market Size by Country/Region (2020-2025)
4.2.1 Global Lying Silkworm Pen Annual Sales by Country/Region (2020-2025)
4.2.2 Global Lying Silkworm Pen Annual Revenue by Country/Region (2020-2025)
4.3 Americas Lying Silkworm Pen Sales Growth
4.4 APAC Lying Silkworm Pen Sales Growth
4.5 Europe Lying Silkworm Pen Sales Growth
4.6 Middle East & Africa Lying Silkworm Pen Sales Growth
5 AMERICAS
5.1 Americas Lying Silkworm Pen Sales by Country
5.1.1 Americas Lying Silkworm Pen Sales by Country (2020-2025)
5.1.2 Americas Lying Silkworm Pen Revenue by Country (2020-2025)
5.2 Americas Lying Silkworm Pen Sales by Type (2020-2025)
5.3 Americas Lying Silkworm Pen Sales by Sale Channel (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lying Silkworm Pen Sales by Region
6.1.1 APAC Lying Silkworm Pen Sales by Region (2020-2025)
6.1.2 APAC Lying Silkworm Pen Revenue by Region (2020-2025)
6.2 APAC Lying Silkworm Pen Sales by Type (2020-2025)
6.3 APAC Lying Silkworm Pen Sales by Sale Channel (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Lying Silkworm Pen by Country
7.1.1 Europe Lying Silkworm Pen Sales by Country (2020-2025)
7.1.2 Europe Lying Silkworm Pen Revenue by Country (2020-2025)
7.2 Europe Lying Silkworm Pen Sales by Type (2020-2025)
7.3 Europe Lying Silkworm Pen Sales by Sale Channel (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Lying Silkworm Pen by Country
8.1.1 Middle East & Africa Lying Silkworm Pen Sales by Country (2020-2025)
8.1.2 Middle East & Africa Lying Silkworm Pen Revenue by Country (2020-2025)
8.2 Middle East & Africa Lying Silkworm Pen Sales by Type (2020-2025)
8.3 Middle East & Africa Lying Silkworm Pen Sales by Sale Channel (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Lying Silkworm Pen
10.3 Manufacturing Process Analysis of Lying Silkworm Pen
10.4 Industry Chain Structure of Lying Silkworm Pen
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Lying Silkworm Pen Distributors
11.3 Lying Silkworm Pen Customer
12 WORLD FORECAST REVIEW FOR LYING SILKWORM PEN BY GEOGRAPHIC REGION
12.1 Global Lying Silkworm Pen Market Size Forecast by Region
12.1.1 Global Lying Silkworm Pen Forecast by Region (2026-2031)
12.1.2 Global Lying Silkworm Pen Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Lying Silkworm Pen Forecast by Type (2026-2031)
12.7 Global Lying Silkworm Pen Forecast by Sale Channel (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Holika
13.1.1 Holika Company Information
13.1.2 Holika Lying Silkworm Pen Product Portfolios and Specifications
13.1.3 Holika Lying Silkworm Pen Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Holika Main Business Overview
13.1.5 Holika Latest Developments
13.2 Lovedrops
13.2.1 Lovedrops Company Information
13.2.2 Lovedrops Lying Silkworm Pen Product Portfolios and Specifications
13.2.3 Lovedrops Lying Silkworm Pen Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Lovedrops Main Business Overview
13.2.5 Lovedrops Latest Developments
13.3 Kate
13.3.1 Kate Company Information
13.3.2 Kate Lying Silkworm Pen Product Portfolios and Specifications
13.3.3 Kate Lying Silkworm Pen Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Kate Main Business Overview
13.3.5 Kate Latest Developments
13.4 Dolly Wink
13.4.1 Dolly Wink Company Information
13.4.2 Dolly Wink Lying Silkworm Pen Product Portfolios and Specifications
13.4.3 Dolly Wink Lying Silkworm Pen Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Dolly Wink Main Business Overview
13.4.5 Dolly Wink Latest Developments
13.5 Solone
13.5.1 Solone Company Information
13.5.2 Solone Lying Silkworm Pen Product Portfolios and Specifications
13.5.3 Solone Lying Silkworm Pen Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Solone Main Business Overview
13.5.5 Solone Latest Developments
13.6 Etude House
13.6.1 Etude House Company Information
13.6.2 Etude House Lying Silkworm Pen Product Portfolios and Specifications
13.6.3 Etude House Lying Silkworm Pen Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Etude House Main Business Overview
13.6.5 Etude House Latest Developments
13.7 Innisfree
13.7.1 Innisfree Company Information
13.7.2 Innisfree Lying Silkworm Pen Product Portfolios and Specifications
13.7.3 Innisfree Lying Silkworm Pen Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Innisfree Main Business Overview
13.7.5 Innisfree Latest Developments
13.8 NYX
13.8.1 NYX Company Information
13.8.2 NYX Lying Silkworm Pen Product Portfolios and Specifications
13.8.3 NYX Lying Silkworm Pen Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 NYX Main Business Overview
13.8.5 NYX Latest Developments
13.9 Banila co
13.9.1 Banila co Company Information
13.9.2 Banila co Lying Silkworm Pen Product Portfolios and Specifications
13.9.3 Banila co Lying Silkworm Pen Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Banila co Main Business Overview
13.9.5 Banila co Latest Developments
13.10 Integrate
13.10.1 Integrate Company Information
13.10.2 Integrate Lying Silkworm Pen Product Portfolios and Specifications
13.10.3 Integrate Lying Silkworm Pen Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Integrate Main Business Overview
13.10.5 Integrate Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Measles Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Measles Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Mumps Measles Rubella Vaccine, Live (MMR-II)
Table 4. Major Players of Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
Table 5. Global Measles Vaccine Sales by Type (2020-2025) & (K MT)
Table 6. Global Measles Vaccine Sales Market Share by Type (2020-2025)
Table 7. Global Measles Vaccine Revenue by Type (2020-2025) & ($ million)
Table 8. Global Measles Vaccine Revenue Market Share by Type (2020-2025)
Table 9. Global Measles Vaccine Sale Price by Type (2020-2025) & (USD/MT)
Table 10. Global Measles Vaccine Sale by Application (2020-2025) & (K MT)
Table 11. Global Measles Vaccine Sale Market Share by Application (2020-2025)
Table 12. Global Measles Vaccine Revenue by Application (2020-2025) & ($ million)
Table 13. Global Measles Vaccine Revenue Market Share by Application (2020-2025)
Table 14. Global Measles Vaccine Sale Price by Application (2020-2025) & (USD/MT)
Table 15. Global Measles Vaccine Sales by Company (2020-2025) & (K MT)
Table 16. Global Measles Vaccine Sales Market Share by Company (2020-2025)
Table 17. Global Measles Vaccine Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Measles Vaccine Revenue Market Share by Company (2020-2025)
Table 19. Global Measles Vaccine Sale Price by Company (2020-2025) & (USD/MT)
Table 20. Key Manufacturers Measles Vaccine Producing Area Distribution and Sales Area
Table 21. Players Measles Vaccine Products Offered
Table 22. Measles Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Measles Vaccine Sales by Geographic Region (2020-2025) & (K MT)
Table 26. Global Measles Vaccine Sales Market Share Geographic Region (2020-2025)
Table 27. Global Measles Vaccine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Measles Vaccine Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Measles Vaccine Sales by Country/Region (2020-2025) & (K MT)
Table 30. Global Measles Vaccine Sales Market Share by Country/Region (2020-2025)
Table 31. Global Measles Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Measles Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Measles Vaccine Sales by Country (2020-2025) & (K MT)
Table 34. Americas Measles Vaccine Sales Market Share by Country (2020-2025)
Table 35. Americas Measles Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Measles Vaccine Sales by Type (2020-2025) & (K MT)
Table 37. Americas Measles Vaccine Sales by Application (2020-2025) & (K MT)
Table 38. APAC Measles Vaccine Sales by Region (2020-2025) & (K MT)
Table 39. APAC Measles Vaccine Sales Market Share by Region (2020-2025)
Table 40. APAC Measles Vaccine Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Measles Vaccine Sales by Type (2020-2025) & (K MT)
Table 42. APAC Measles Vaccine Sales by Application (2020-2025) & (K MT)
Table 43. Europe Measles Vaccine Sales by Country (2020-2025) & (K MT)
Table 44. Europe Measles Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Measles Vaccine Sales by Type (2020-2025) & (K MT)
Table 46. Europe Measles Vaccine Sales by Application (2020-2025) & (K MT)
Table 47. Middle East & Africa Measles Vaccine Sales by Country (2020-2025) & (K MT)
Table 48. Middle East & Africa Measles Vaccine Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Measles Vaccine Sales by Type (2020-2025) & (K MT)
Table 50. Middle East & Africa Measles Vaccine Sales by Application (2020-2025) & (K MT)
Table 51. Key Market Drivers & Growth Opportunities of Measles Vaccine
Table 52. Key Market Challenges & Risks of Measles Vaccine
Table 53. Key Industry Trends of Measles Vaccine
Table 54. Measles Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Measles Vaccine Distributors List
Table 57. Measles Vaccine Customer List
Table 58. Global Measles Vaccine Sales Forecast by Region (2026-2031) & (K MT)
Table 59. Global Measles Vaccine Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Measles Vaccine Sales Forecast by Country (2026-2031) & (K MT)
Table 61. Americas Measles Vaccine Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Measles Vaccine Sales Forecast by Region (2026-2031) & (K MT)
Table 63. APAC Measles Vaccine Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Measles Vaccine Sales Forecast by Country (2026-2031) & (K MT)
Table 65. Europe Measles Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Measles Vaccine Sales Forecast by Country (2026-2031) & (K MT)
Table 67. Middle East & Africa Measles Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Measles Vaccine Sales Forecast by Type (2026-2031) & (K MT)
Table 69. Global Measles Vaccine Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Measles Vaccine Sales Forecast by Application (2026-2031) & (K MT)
Table 71. Global Measles Vaccine Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. GSK Basic Information, Measles Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. GSK Measles Vaccine Product Portfolios and Specifications
Table 74. GSK Measles Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. GSK Main Business
Table 76. GSK Latest Developments
Table 77. Sanofi-Pasteur Basic Information, Measles Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. Sanofi-Pasteur Measles Vaccine Product Portfolios and Specifications
Table 79. Sanofi-Pasteur Measles Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 80. Sanofi-Pasteur Main Business
Table 81. Sanofi-Pasteur Latest Developments
Table 82. Merck Basic Information, Measles Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Merck Measles Vaccine Product Portfolios and Specifications
Table 84. Merck Measles Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Merck Main Business
Table 86. Merck Latest Developments
Table 87. Novartis Basic Information, Measles Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Novartis Measles Vaccine Product Portfolios and Specifications
Table 89. Novartis Measles Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 90. Novartis Main Business
Table 91. Novartis Latest Developments
Table 92. Pfizer Basic Information, Measles Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Pfizer Measles Vaccine Product Portfolios and Specifications
Table 94. Pfizer Measles Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 95. Pfizer Main Business
Table 96. Pfizer Latest Developments
Table 97. Serum Institute of India Basic Information, Measles Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Serum Institute of India Measles Vaccine Product Portfolios and Specifications
Table 99. Serum Institute of India Measles Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 100. Serum Institute of India Main Business
Table 101. Serum Institute of India Latest Developments
Table 102. China National Biotech Group Basic Information, Measles Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. China National Biotech Group Measles Vaccine Product Portfolios and Specifications
Table 104. China National Biotech Group Measles Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 105. China National Biotech Group Main Business
Table 106. China National Biotech Group Latest Developments
Table 107. Bavarian Nordic Basic Information, Measles Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Bavarian Nordic Measles Vaccine Product Portfolios and Specifications
Table 109. Bavarian Nordic Measles Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Bavarian Nordic Main Business
Table 111. Bavarian Nordic Latest Developments
Table 112. Emergent Biosolutions Basic Information, Measles Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. Emergent Biosolutions Measles Vaccine Product Portfolios and Specifications
Table 114. Emergent Biosolutions Measles Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 115. Emergent Biosolutions Main Business
Table 116. Emergent Biosolutions Latest Developments
Table 117. Medimmune Basic Information, Measles Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. Medimmune Measles Vaccine Product Portfolios and Specifications
Table 119. Medimmune Measles Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 120. Medimmune Main Business
Table 121. Medimmune Latest Developments
Table 122. Johnson & Johnson Basic Information, Measles Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. Johnson & Johnson Measles Vaccine Product Portfolios and Specifications
Table 124. Johnson & Johnson Measles Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 125. Johnson & Johnson Main Business
Table 126. Johnson & Johnson Latest Developments
Table 127. CSL Limited Basic Information, Measles Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 128. CSL Limited Measles Vaccine Product Portfolios and Specifications
Table 129. CSL Limited Measles Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 130. CSL Limited Main Business
Table 131. CSL Limited Latest Developments
Table 1. Measles Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Measles Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Mumps Measles Rubella Vaccine, Live (MMR-II)
Table 4. Major Players of Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
Table 5. Global Measles Vaccine Sales by Type (2020-2025) & (K MT)
Table 6. Global Measles Vaccine Sales Market Share by Type (2020-2025)
Table 7. Global Measles Vaccine Revenue by Type (2020-2025) & ($ million)
Table 8. Global Measles Vaccine Revenue Market Share by Type (2020-2025)
Table 9. Global Measles Vaccine Sale Price by Type (2020-2025) & (USD/MT)
Table 10. Global Measles Vaccine Sale by Application (2020-2025) & (K MT)
Table 11. Global Measles Vaccine Sale Market Share by Application (2020-2025)
Table 12. Global Measles Vaccine Revenue by Application (2020-2025) & ($ million)
Table 13. Global Measles Vaccine Revenue Market Share by Application (2020-2025)
Table 14. Global Measles Vaccine Sale Price by Application (2020-2025) & (USD/MT)
Table 15. Global Measles Vaccine Sales by Company (2020-2025) & (K MT)
Table 16. Global Measles Vaccine Sales Market Share by Company (2020-2025)
Table 17. Global Measles Vaccine Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Measles Vaccine Revenue Market Share by Company (2020-2025)
Table 19. Global Measles Vaccine Sale Price by Company (2020-2025) & (USD/MT)
Table 20. Key Manufacturers Measles Vaccine Producing Area Distribution and Sales Area
Table 21. Players Measles Vaccine Products Offered
Table 22. Measles Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Measles Vaccine Sales by Geographic Region (2020-2025) & (K MT)
Table 26. Global Measles Vaccine Sales Market Share Geographic Region (2020-2025)
Table 27. Global Measles Vaccine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Measles Vaccine Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Measles Vaccine Sales by Country/Region (2020-2025) & (K MT)
Table 30. Global Measles Vaccine Sales Market Share by Country/Region (2020-2025)
Table 31. Global Measles Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Measles Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Measles Vaccine Sales by Country (2020-2025) & (K MT)
Table 34. Americas Measles Vaccine Sales Market Share by Country (2020-2025)
Table 35. Americas Measles Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Measles Vaccine Sales by Type (2020-2025) & (K MT)
Table 37. Americas Measles Vaccine Sales by Application (2020-2025) & (K MT)
Table 38. APAC Measles Vaccine Sales by Region (2020-2025) & (K MT)
Table 39. APAC Measles Vaccine Sales Market Share by Region (2020-2025)
Table 40. APAC Measles Vaccine Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Measles Vaccine Sales by Type (2020-2025) & (K MT)
Table 42. APAC Measles Vaccine Sales by Application (2020-2025) & (K MT)
Table 43. Europe Measles Vaccine Sales by Country (2020-2025) & (K MT)
Table 44. Europe Measles Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Measles Vaccine Sales by Type (2020-2025) & (K MT)
Table 46. Europe Measles Vaccine Sales by Application (2020-2025) & (K MT)
Table 47. Middle East & Africa Measles Vaccine Sales by Country (2020-2025) & (K MT)
Table 48. Middle East & Africa Measles Vaccine Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Measles Vaccine Sales by Type (2020-2025) & (K MT)
Table 50. Middle East & Africa Measles Vaccine Sales by Application (2020-2025) & (K MT)
Table 51. Key Market Drivers & Growth Opportunities of Measles Vaccine
Table 52. Key Market Challenges & Risks of Measles Vaccine
Table 53. Key Industry Trends of Measles Vaccine
Table 54. Measles Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Measles Vaccine Distributors List
Table 57. Measles Vaccine Customer List
Table 58. Global Measles Vaccine Sales Forecast by Region (2026-2031) & (K MT)
Table 59. Global Measles Vaccine Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Measles Vaccine Sales Forecast by Country (2026-2031) & (K MT)
Table 61. Americas Measles Vaccine Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Measles Vaccine Sales Forecast by Region (2026-2031) & (K MT)
Table 63. APAC Measles Vaccine Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Measles Vaccine Sales Forecast by Country (2026-2031) & (K MT)
Table 65. Europe Measles Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Measles Vaccine Sales Forecast by Country (2026-2031) & (K MT)
Table 67. Middle East & Africa Measles Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Measles Vaccine Sales Forecast by Type (2026-2031) & (K MT)
Table 69. Global Measles Vaccine Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Measles Vaccine Sales Forecast by Application (2026-2031) & (K MT)
Table 71. Global Measles Vaccine Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. GSK Basic Information, Measles Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. GSK Measles Vaccine Product Portfolios and Specifications
Table 74. GSK Measles Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. GSK Main Business
Table 76. GSK Latest Developments
Table 77. Sanofi-Pasteur Basic Information, Measles Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. Sanofi-Pasteur Measles Vaccine Product Portfolios and Specifications
Table 79. Sanofi-Pasteur Measles Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 80. Sanofi-Pasteur Main Business
Table 81. Sanofi-Pasteur Latest Developments
Table 82. Merck Basic Information, Measles Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Merck Measles Vaccine Product Portfolios and Specifications
Table 84. Merck Measles Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Merck Main Business
Table 86. Merck Latest Developments
Table 87. Novartis Basic Information, Measles Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Novartis Measles Vaccine Product Portfolios and Specifications
Table 89. Novartis Measles Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 90. Novartis Main Business
Table 91. Novartis Latest Developments
Table 92. Pfizer Basic Information, Measles Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Pfizer Measles Vaccine Product Portfolios and Specifications
Table 94. Pfizer Measles Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 95. Pfizer Main Business
Table 96. Pfizer Latest Developments
Table 97. Serum Institute of India Basic Information, Measles Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Serum Institute of India Measles Vaccine Product Portfolios and Specifications
Table 99. Serum Institute of India Measles Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 100. Serum Institute of India Main Business
Table 101. Serum Institute of India Latest Developments
Table 102. China National Biotech Group Basic Information, Measles Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. China National Biotech Group Measles Vaccine Product Portfolios and Specifications
Table 104. China National Biotech Group Measles Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 105. China National Biotech Group Main Business
Table 106. China National Biotech Group Latest Developments
Table 107. Bavarian Nordic Basic Information, Measles Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Bavarian Nordic Measles Vaccine Product Portfolios and Specifications
Table 109. Bavarian Nordic Measles Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Bavarian Nordic Main Business
Table 111. Bavarian Nordic Latest Developments
Table 112. Emergent Biosolutions Basic Information, Measles Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. Emergent Biosolutions Measles Vaccine Product Portfolios and Specifications
Table 114. Emergent Biosolutions Measles Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 115. Emergent Biosolutions Main Business
Table 116. Emergent Biosolutions Latest Developments
Table 117. Medimmune Basic Information, Measles Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. Medimmune Measles Vaccine Product Portfolios and Specifications
Table 119. Medimmune Measles Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 120. Medimmune Main Business
Table 121. Medimmune Latest Developments
Table 122. Johnson & Johnson Basic Information, Measles Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. Johnson & Johnson Measles Vaccine Product Portfolios and Specifications
Table 124. Johnson & Johnson Measles Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 125. Johnson & Johnson Main Business
Table 126. Johnson & Johnson Latest Developments
Table 127. CSL Limited Basic Information, Measles Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 128. CSL Limited Measles Vaccine Product Portfolios and Specifications
Table 129. CSL Limited Measles Vaccine Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 130. CSL Limited Main Business
Table 131. CSL Limited Latest Developments
LIST OF FIGURES
Figure 1. Picture of Measles Vaccine
Figure 2. Measles Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Measles Vaccine Sales Growth Rate 2020-2031 (K MT)
Figure 7. Global Measles Vaccine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Measles Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Measles Vaccine Sales Market Share by Country/Region (2024)
Figure 10. Measles Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Mumps Measles Rubella Vaccine, Live (MMR-II)
Figure 12. Product Picture of Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
Figure 13. Global Measles Vaccine Sales Market Share by Type in 2025
Figure 14. Global Measles Vaccine Revenue Market Share by Type (2020-2025)
Figure 15. Measles Vaccine Consumed in Children
Figure 16. Global Measles Vaccine Market: Children (2020-2025) & (K MT)
Figure 17. Measles Vaccine Consumed in Adults
Figure 18. Global Measles Vaccine Market: Adults (2020-2025) & (K MT)
Figure 19. Global Measles Vaccine Sale Market Share by Application (2024)
Figure 20. Global Measles Vaccine Revenue Market Share by Application in 2025
Figure 21. Measles Vaccine Sales by Company in 2025 (K MT)
Figure 22. Global Measles Vaccine Sales Market Share by Company in 2025
Figure 23. Measles Vaccine Revenue by Company in 2025 ($ millions)
Figure 24. Global Measles Vaccine Revenue Market Share by Company in 2025
Figure 25. Global Measles Vaccine Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Measles Vaccine Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Measles Vaccine Sales 2020-2025 (K MT)
Figure 28. Americas Measles Vaccine Revenue 2020-2025 ($ millions)
Figure 29. APAC Measles Vaccine Sales 2020-2025 (K MT)
Figure 30. APAC Measles Vaccine Revenue 2020-2025 ($ millions)
Figure 31. Europe Measles Vaccine Sales 2020-2025 (K MT)
Figure 32. Europe Measles Vaccine Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Measles Vaccine Sales 2020-2025 (K MT)
Figure 34. Middle East & Africa Measles Vaccine Revenue 2020-2025 ($ millions)
Figure 35. Americas Measles Vaccine Sales Market Share by Country in 2025
Figure 36. Americas Measles Vaccine Revenue Market Share by Country (2020-2025)
Figure 37. Americas Measles Vaccine Sales Market Share by Type (2020-2025)
Figure 38. Americas Measles Vaccine Sales Market Share by Application (2020-2025)
Figure 39. United States Measles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Measles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Measles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Measles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Measles Vaccine Sales Market Share by Region in 2025
Figure 44. APAC Measles Vaccine Revenue Market Share by Region (2020-2025)
Figure 45. APAC Measles Vaccine Sales Market Share by Type (2020-2025)
Figure 46. APAC Measles Vaccine Sales Market Share by Application (2020-2025)
Figure 47. China Measles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Measles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Measles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Measles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 51. India Measles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Measles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 53. China Taiwan Measles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Measles Vaccine Sales Market Share by Country in 2025
Figure 55. Europe Measles Vaccine Revenue Market Share by Country (2020-2025)
Figure 56. Europe Measles Vaccine Sales Market Share by Type (2020-2025)
Figure 57. Europe Measles Vaccine Sales Market Share by Application (2020-2025)
Figure 58. Germany Measles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 59. France Measles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Measles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Measles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Measles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Measles Vaccine Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Measles Vaccine Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Measles Vaccine Sales Market Share by Application (2020-2025)
Figure 66. Egypt Measles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Measles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Measles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Measles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Measles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Measles Vaccine in 2025
Figure 72. Manufacturing Process Analysis of Measles Vaccine
Figure 73. Industry Chain Structure of Measles Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Measles Vaccine Sales Market Forecast by Region (2026-2031)
Figure 76. Global Measles Vaccine Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Measles Vaccine Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Measles Vaccine Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Measles Vaccine Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Measles Vaccine Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Measles Vaccine
Figure 2. Measles Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Measles Vaccine Sales Growth Rate 2020-2031 (K MT)
Figure 7. Global Measles Vaccine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Measles Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Measles Vaccine Sales Market Share by Country/Region (2024)
Figure 10. Measles Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Mumps Measles Rubella Vaccine, Live (MMR-II)
Figure 12. Product Picture of Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
Figure 13. Global Measles Vaccine Sales Market Share by Type in 2025
Figure 14. Global Measles Vaccine Revenue Market Share by Type (2020-2025)
Figure 15. Measles Vaccine Consumed in Children
Figure 16. Global Measles Vaccine Market: Children (2020-2025) & (K MT)
Figure 17. Measles Vaccine Consumed in Adults
Figure 18. Global Measles Vaccine Market: Adults (2020-2025) & (K MT)
Figure 19. Global Measles Vaccine Sale Market Share by Application (2024)
Figure 20. Global Measles Vaccine Revenue Market Share by Application in 2025
Figure 21. Measles Vaccine Sales by Company in 2025 (K MT)
Figure 22. Global Measles Vaccine Sales Market Share by Company in 2025
Figure 23. Measles Vaccine Revenue by Company in 2025 ($ millions)
Figure 24. Global Measles Vaccine Revenue Market Share by Company in 2025
Figure 25. Global Measles Vaccine Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Measles Vaccine Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Measles Vaccine Sales 2020-2025 (K MT)
Figure 28. Americas Measles Vaccine Revenue 2020-2025 ($ millions)
Figure 29. APAC Measles Vaccine Sales 2020-2025 (K MT)
Figure 30. APAC Measles Vaccine Revenue 2020-2025 ($ millions)
Figure 31. Europe Measles Vaccine Sales 2020-2025 (K MT)
Figure 32. Europe Measles Vaccine Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Measles Vaccine Sales 2020-2025 (K MT)
Figure 34. Middle East & Africa Measles Vaccine Revenue 2020-2025 ($ millions)
Figure 35. Americas Measles Vaccine Sales Market Share by Country in 2025
Figure 36. Americas Measles Vaccine Revenue Market Share by Country (2020-2025)
Figure 37. Americas Measles Vaccine Sales Market Share by Type (2020-2025)
Figure 38. Americas Measles Vaccine Sales Market Share by Application (2020-2025)
Figure 39. United States Measles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Measles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Measles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Measles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Measles Vaccine Sales Market Share by Region in 2025
Figure 44. APAC Measles Vaccine Revenue Market Share by Region (2020-2025)
Figure 45. APAC Measles Vaccine Sales Market Share by Type (2020-2025)
Figure 46. APAC Measles Vaccine Sales Market Share by Application (2020-2025)
Figure 47. China Measles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Measles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Measles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Measles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 51. India Measles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Measles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 53. China Taiwan Measles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Measles Vaccine Sales Market Share by Country in 2025
Figure 55. Europe Measles Vaccine Revenue Market Share by Country (2020-2025)
Figure 56. Europe Measles Vaccine Sales Market Share by Type (2020-2025)
Figure 57. Europe Measles Vaccine Sales Market Share by Application (2020-2025)
Figure 58. Germany Measles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 59. France Measles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Measles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Measles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Measles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Measles Vaccine Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Measles Vaccine Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Measles Vaccine Sales Market Share by Application (2020-2025)
Figure 66. Egypt Measles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Measles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Measles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Measles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Measles Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Measles Vaccine in 2025
Figure 72. Manufacturing Process Analysis of Measles Vaccine
Figure 73. Industry Chain Structure of Measles Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Measles Vaccine Sales Market Forecast by Region (2026-2031)
Figure 76. Global Measles Vaccine Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Measles Vaccine Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Measles Vaccine Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Measles Vaccine Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Measles Vaccine Revenue Market Share Forecast by Application (2026-2031)
